Skip to main content
logo
ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.085
-0.045 (-1.09%)
Feb 19, 2026, 12:00 PM EST - Market open

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '19 Dec '18 Dec '17
Antibody Drug Conjugate Cancer Therapies
70.84M
Antibody Drug Conjugate Cancer Therapies Growth
1.84%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2019FY 2018FY 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '19 Dec '18 Dec '17
United States
69.28M
United States Growth
0.32%
EMEA
1.56M
EMEA Growth
212.65%